Watch Episode Six to hear Katie’s honest perspective on dry skin care — and explore how brands can better serve consumers ...

8% of patients maintained that the ongoing war had affected the quality of the treatment they are receiving for psoriasis.

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

About 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may ...

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

But this bump was different. It grew quickly, and within three months, it became a mass half an inch off his skin that ...

At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life ...

THURSDAY, May 29, 2025 (HealthDay News) — Belly flab appears to be a stronger warning sign for psoriasis than fat located ...

Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...